Results for Glucagon-Like Peptide 1

Publications & Outputs

1. Lixisenatide, a drug developed to treat type 2 diabetes, shows neuroprotective effects in a mouse model of Alzheimer's disease

   McClean, P. L. & Holscher, C., 11/2014, In: Neuropharmacology. 86, p. 241-258 18 p.

   Research output: Contribution to Journal/Magazine › Journal article › peer-review

2. Liraglutide improves hippocampal synaptic plasticity associated with increased expression of Mash1 in ob/ob mice

   Porter, W. D., Flatt, P. R., Hölscher, C. & Gault, V. A., 05/2013, In: International Journal of Obesity. 37, 5, p. 678-684 7 p.

   Research output: Contribution to Journal/Magazine › Journal article › peer-review

3. Val⁸-GLP-1 remodels synaptic activity and intracellular calcium homeostasis impaired by amyloid β peptide in rats

   Wang, X-H., Yang, W., Hölscher, C., Wang, Z-J., Cai, H-Y., Li, Q-S. & Qi, J-S., 04/2013, In: Journal of Neuroscience Research. 91, 4, p. 568-577 10 p.

   Research output: Contribution to Journal/Magazine › Journal article › peer-review

4. The diabetes drug liraglutide ameliorates aberrant insulin receptor localisation and signalling in parallel with decreasing both amyloid-β plaque and glial pathology in a mouse model of Alzheimer's disease

   Long-Smith, C. M., Manning, S., McClean, P. L., Coakley, M. F., O'Halloran, D. J., Holscher, C. & O'Neill, C., 03/2013, In: NeuroMolecular Medicine. 15, 1, p. 102-114 13 p.

   Research output: Contribution to Journal/Magazine › Journal article › peer-review

5. Liraglutide protects against amyloid-β protein-induced impairment of spatial learning and memory in rats

   Han, W-N., Hölscher, C., Yuan, L., Yang, W., Wang, X-H., Wu, M-N. & Qi, J-S., 02/2013, In: Neurobiology of Aging. 34, 2, p. 576-588 13 p.

   Research output: Contribution to Journal/Magazine › Journal article › peer-review

6. The type 2 diabetes drug liraglutide reduces chronic inflammation induced by irradiation in the mouse brain

   Parthsarathy, V. & Hölscher, C., 30/01/2013, In: European Journal of Pharmacology. 700, 1-3, p. 42-50 9 p.

   Research output: Contribution to Journal/Magazine › Journal article › peer-review

7. Effects of the glucagon-like polypeptide-1 analogue (Val8)GLP-1 on learning, progenitor cell proliferation and neurogenesis in the C57B/16 mouse brain

   McGovern, S. F. J., Hunter, K. & Hölscher, C., 14/09/2012, In: Brain Research. 1473, p. 204-213 10 p.

   Research output: Contribution to Journal/Magazine › Journal article › peer-review

8. (Val⁸) glucagon-like peptide-1 prevents tau hyperphosphorylation, impairment of spatial learning and ultra-structural cellular damage induced by streptozotocin in rat brains

   Li, L., Zhang, Z-F., Hölscher, C., Gao, C., Jiang, Y-H. & Liu, Y-Z., 15/01/2012, In: European Journal of Pharmacology. 674, 2-3, p. 280-286 7 p.

   Research output: Contribution to Journal/Magazine › Journal article › peer-review

9. Novel GLP-1 mimetics developed to treat type 2 diabetes promote progenitor cell proliferation in the brain

   Hamilton, A., Patterson, S., Porter, D., Gault, V. A. & Hölscher, C., 04/2011, In: Journal of Neuroscience Research. 89, 4, p. 481-489 9 p.

   Research output: Contribution to Journal/Magazine › Journal article › peer-review

10. Four weeks administration of Liraglutide improves memory and learning as well as glycaemic control in mice with high fat dietary-induced obesity and insulin resistance

    Porter, D. W., Kerr, B. D., Flatt, P. R., Hölscher, C. & Gault, V. A., 10/2010, In: Diabetes, Obesity and Metabolism. 12, 10, p. 891-899 9 p.

    Research output: Contribution to Journal/Magazine › Journal article › peer-review

11. Incretin analogues that have been developed to treat type 2 diabetes hold promise as a novel treatment strategy for Alzheimer's disease

    Hölscher, C., 06/2010, In: Recent Patents on CNS Drug Discovery. 5, 2, p. 109-117 9 p.

    Research output: Contribution to Journal/Magazine › Journal article › peer-review

More results »